[1] Palakurthi S, Yellepeddi VK, Vangara KK. Recent trends in cancer drug resistance reversal strategies using nanoparticles[J]. Expert Opin Drug Deliv, 2012, 9(3):287-301.
[2] Shapira A, LivneyY D, Broxterman H J, et al. Nanomedicine for targeted cancer therapy:towards the overcoming of drug resistance[J]. Drug Resist Updat, 2011, 14(3):150-163.
[3] Patil YB, Swaminathan SK, Sadhukha T, et al. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance[J]. Biomaterials, 2010, 31(2):358-365.
[4] Song XR, Cai Z, Zheng Y, et al. Reversion of multidrug resistance by coencapsulation of vincristine and verapamil in PLGA nanoparticles[J]. Eur J Pharm Sci, 2009, 37(3-4):300-305.
[5] Khdair A, Handa H, Mao GZ, et al. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro[J]. Eur J Pharm Biopharm, 2009, 71(2):214-222.
[6] Lee ES, Gao ZG, Kim D, et a1. Super pH-sensitive multifunctional polymeric micelle for tumor pH(e)specific TAT exposure and multidrug resistance[J]. J Control Rel, 2008, 129(3):228.
[7] Chen B, Sun Q, Wang X, et al. Reversal in multidrug resistance by magnetic nanoparticle of Fe3O4 loaded with adriamycin and tetrandrine in K562/A02 leukemic cells[J]. Int J Nanomedicine, 2008, 3(2):277-286.
[8] Chen BA, Cheng J, Shen MF, et al. Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells[J]. Int J Nanomedicine, 2009, 4:65-71.
[9] Chen BA, Lai BB, Cheng J, et al. Daunorubicin-loaded magnetic nanoparticles of Fe3O4 overcome multidrug resistance and induce apoptosis of K562-n/VCR cells in vivo[J]. Int J Nanomed, 2009, 4:201-208.
[10] Chen AM, Zhang M, Wei DG, et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells[J]. Small, 2009, 5(23):2673-2677.
[11] WangY, Saad M, Pakunlu RI, et al. Nonviral nanoscale-based delivery of antisense oligonucleotides targeted to hypoxia-inducible factor 1 alpha enhances the efficacy of chemotherapy in drug-resistant tumor[J]. Clin Cancer Res, 2008, 14(11):3607-3616.
[12] Devalapally H, Duan ZF, Seiden MV, et al. Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles[J]. Clin Cancer Res, 2008,14(10):3193-3203.
[13] Fan L, Li F, Zhang HT, et al. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance[J]. Biomaterials, 2010, 31(21):5634-5642.
[14] Susa M, Iyer AK, Ryu K, et al. Doxorubicin loaded polymeric nanoparticulate delivery system to overcome drug resistance in osteosarcoma[J]. BMC Cancer,2009, 9:399.
[15] Susa M, Iyer AK, Ryu K, et al. Inhibition of ABCB1(MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma[J]. PLoS One, 2010, 5(5):e10764.